Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.102
-0.008 (-0.72%)
At close: Mar 27, 2026, 4:00 PM EDT
1.110
+0.008 (0.73%)
After-hours: Mar 27, 2026, 4:00 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $24.87 million as of March 27, 2026. Its market cap has decreased by -31.15% in one year.
Market Cap
24.87M
Enterprise Value
-33.67M
1-Year Change
-31.15%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $24.87M, a decrease of -93.01%. That is a compound annual growth rate of -73.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 24.87M | -7.40% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 26.94M |
| Lixte Biotechnology Holdings | 26.92M |
| Kyntra Bio | 26.67M |
| CEL-SCI | 25.90M |
| Dyadic International | 24.73M |
| ABVC BioPharma | 24.71M |
| Serina Therapeutics | 24.48M |
| IGC Pharma | 24.46M |